T3098C and T53C mutations of HBV genotype C Is associated with HBV infection progress

Biomedical and Environmental Sciences

Volumn 22, Issue 6, 2009, Pages 511-517

  Jianq, S U Zhen ^a   Gao, Zhi Yong ^a   Tong, L I ^a   Li, Ya Juan ^a   Chen, Xiang Mei ^a   Wang, Ling ^a   Lu , Feng Min ^a   Hui, Zhuang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Genotype c; Hepatitis b virus (HBV); Hepatocellular carcinoma (HCC); Mutation; Pres

Indexed keywords

HEPATITIS B VIRUS;

EID: 77649171356     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(10)60009-8     Document Type: Article

References (42)

1. Data on 2006 seroepidemiological survey on HBV infection in China. Accessed April 21, 2008 at http://www.moh.gov.cn.
2. Lu F, Zhuang H (2009). Management of hepatitis B in China. Chin J Med 122,3-4.
3. 3. Okamoto H, Tsuda F, Sakugawa H, et al. (1988). Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69, 2575-2583. (Pubitemid 18242724)
4. 4. Norder H, Courouce A M, Magnius L O. (1994). Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198, 489-503. (Pubitemid 124019485)
5. 5. Stuyver L, De Gendt S, Van Geyt C, et al.(2000). A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81, 67-74. (Pubitemid 30047907)
6. 6. Arauz-Ruiz P, Norder H, Robertson B H, et al. (2002). Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83, 2059-2073. (Pubitemid 34846468)
7. 7. Chu C J, Keeffe E B, Han S H, et al. (2003). Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125, 444-451. (Pubitemid 36929426)
8. 8. Huy T T, Abe K (2004). Molecular epidemiology of hepatitis B and C virus infections in Asia. Pediatr Int 46, 223-230 (Pubitemid 38526624)
9. 9. Campos R H, Mbayed V A, Pineiro Y, et al. (2005). Molecular epidemiology of hepatitis B virus in Latin America. J Clin Virol 34, 8-13. (Pubitemid 43197766)
10. 10. Kramvis A, Kew M C (2007). Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37, 9-19. (Pubitemid 47086511)
11. Schaefer S (2007). Hepatitis B virus genotypes in Europe. Hepatol Res 37, 20-26.
12. 12.Wang Z, Huang Y, Wen S, et al. (2007). Hepatitis B virus genotypes and subgenotypes in China. Hepatol Res 37, 36-41 (Pubitemid 47086514)
13. Fan J, Zhuang H, Li Y. (1997). Comparison of sequences of hepatitis B virus S gene fragment in eight cities of China. Chin T Prevent Med 31, 140-143.
14. Xia G, Nainan O V, Jia Z (2001). Characterization and distribution of hepatitis B virus genotypes and subtypes in 4 provinces of China. Chin T Epidemiol 22, 348-351.
15. Xu J, Wang Q X, Fan C L, et al. (2003). Comparison of hepatitis B virus serotype and genotype among HBsAg positive hepatitis B patients in a northern and a southern city of China. Chin T Exp Clin virol 17, 327-329.
16. 16.Zollner B, Petersen J, Puchhammer-Stockl E, et al. (2004). Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology 39, 42-50. (Pubitemid 38461465)
17. 17.Duong T N, Horiike N, Michitaka K, et al. (2004). Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study. J Med Virol 72, 551-557. (Pubitemid 38296066)
18. 18.Yuen M F, Tanaka Y, Mizokami M, et al. (2004). Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis 25, 1593-1598. (Pubitemid 39214301)
19. 19.Palumbo E (2007). Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther 14, 306-309. (Pubitemid 46791570)
20. Lin C L, Kao J H. (2008). Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 15, 137-145.
21. 21.Huy T T, Ushijima H, Win K M, et al. (2003). High prevalence of hepatitis B virus preS mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbials, 5449-5455. (Pubitemid 37543229)
22. Hunt C M, McGiIl J M, Allen M I, et al. (2000). Clinical relevance of hepatitis B viral mutations. Hepatology 31, 1037-1044.
23. Fan Y F, Lu C C, Chen W C, et al. (2001). Prevalence and significance of hepatitis B virus (HBV) preS mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33, 277-286.
24. Chen B F, Liu C J, Jow G M, et al. (2006). High prevalence and mapping of preS deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130, 1153-1168.
25. 25.Gao Z Y, Li T, Wang J, et al. (2007). Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 42, 761-768. (Pubitemid 47456764)
26. de Franchis R, Hadengue A, Lau G, et al. (2003). EASL International Consensus Conference on Hepatitis B. 13-14
27. September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 39, 3-25.
28. Lok A S and Mc Mah B J. (2007). AASLD practice guidelines: Chronic hepatitis B. Hepatology 45, 507-539.
29. 28.Naito H, Hayashi S, Abe K. (2001). Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39, 362-364. (Pubitemid 32059621)
30. Sung J J, Tsui S K, Tse C H, et al. (2008). Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J Virol 82, 3604-3611.
31. Ganem D (1991). Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 168, 61-83.
32. 31.Itoh Y, Takai E, Ohnuma H, et al. (1986). A synthetic peptide vaccine involving the product of the preS (2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83, 9174-9178. (Pubitemid 17223557)
33. Gerlich W H, Deepen R, Heermann K H, et ai. (1990). Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine 8, 63-68.
34. 33.Neurath A R, Seto B, Strick N (1989). Antibodies to synthetic peptides from the prcSl region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7, 234-236. (Pubitemid 19174459)
35. 34.Milich D R, Jones J E, McLachlan A, et al. (1990). Importance of subtype in the immune response to the preS (2) region of the hepatitis B surface antigen. II. Synthetic PreS (2) immunogen. J Immunol 144, 3544-3551. (Pubitemid 20146392)
36. 35.Sugauchi F, Ohno T, Orito E, et al. (2003). Influence of hepatitis B virus genotypes on the development of pres deletions and advanced liver disease. J Med Virol 70, 537-544. (Pubitemid 36734717)
37. Wang H C, Wu H C, Chen C F, et al. (2003). Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific preS mutants that may induce endoplasmic reticulum stress. Am J Pathol 163, 2441-2449.
38. Hsieh Y H, Su I J, Wang H C, etal. (2004). PreS mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25, 2023-2032.
39. 38.Fernholz D, Galle P R, Stemler M, et al. (1993). Infectious hepatitis B virus variant defective in preS2 protein expression in a chronic carrier. Virology 194, 137-148. (Pubitemid 23211746)
40. 39.Pollicino T, Zanetti A R, Cacciola I, et al. (1997). PreS2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26, 495-499. (Pubitemid 27328332)
41. 40.Bruss V, Ganem D. (1991). The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sei USA 88, 1059-1063. (Pubitemid 21916164)
42. 41.Raimondo G, Costantino L, Caccamo G, et al. (2004). Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J Hepatol 40, 515-519. (Pubitemid 38230855)